Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3075% above fair value
$120.37−2.49 (-2.03%)
Close on Nov 19, 2026Market cap $5.48BP/E 58.7Yield –
Haemonetics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Haemonetics's gross profit for the twelve months ending Jun 27, 2026 was $798.15M, up 4.2% year over year. For fiscal 2026 it was $787.59M, up 5.2% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $787.59M in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $787.59M | +5.2% |
| FY2025 | Mar 29, 2025 | $748.96M | +8.3% |
| FY2024 | Mar 30, 2024 | $691.55M | +12.4% |
| FY2023 | Apr 1, 2023 | $615.10M | +21.7% |
| FY2022 | Apr 2, 2022 | $505.50M | +27.1% |
| FY2021 | Apr 3, 2021 | $397.84M | -17.9% |
| FY2020 | Mar 28, 2020 | $484.51M | +16.0% |
| FY2019 | Mar 30, 2019 | $417.54M | +1.4% |
| FY2018 | Mar 31, 2018 | $411.91M | +8.8% |
| FY2017 | Apr 1, 2017 | $378.49M | -6.8% |
| FY2016 | Apr 2, 2016 | $405.91M | -6.6% |
| FY2015 | Mar 28, 2015 | $434.42M | -7.2% |
| FY2014 | Mar 29, 2014 | $468.37M | +9.4% |
| FY2013 | Mar 30, 2013 | $428.13M | +15.9% |
| FY2012 | Mar 31, 2012 | $369.24M | +4.0% |
| FY2011 | Apr 2, 2011 | $355.21M | +5.3% |
| FY2010 | Apr 3, 2010 | $337.48M | +9.5% |
| FY2009 | Mar 28, 2009 | $308.17M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $202.80M | +5.5% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $198.21M | +2.7% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $202.39M | +4.6% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $194.74M | +3.9% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $192.24M | +9.9% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $193.05M | +9.7% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $193.55M | +8.8% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $187.44M | +9.9% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $174.92M | +4.6% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $175.91M | +12.6% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $177.87M | +12.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $170.51M | +8.0% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $167.27M | +17.6% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $156.25M | +14.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $158.71M | +14.5% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $157.88M | +28.8% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $142.26M | +31.6% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $136.31M | +66.6% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $138.57M | +15.2% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $122.54M | +15.9% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $108.09M | +20.1% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $81.81M | -28.0% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $120.26M | -6.1% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $105.74M | -16.7% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $90.03M | -22.3% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $113.56M | +2.1% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $128.05M | +15.2% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $127.00M | +13.5% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $115.91M | +39.2% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $111.21M | +6.5% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $111.18M | -0.1% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $111.91M | +7.0% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $83.24M | -9.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $104.39M | +27.1% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $111.30M | +10.1% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $104.56M | +0.3% |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $91.67M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $82.11M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $101.08M | – |
| Q2 FY2017CQ3 2016 | Oct 1, 2016 | $104.25M | – |
See a number that looks wrong?